TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -16.16%3.37B | ---- | 2.63%4.02B | ---- | 10.95%3.92B | ---- | 11.54%3.53B | ---- | 14.16%3.16B | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -16.85%-191.67M | ---- | -32.96%-164.03M | ---- | 22.65%-123.37M | ---- | -33.65%-159.49M | ---- | -23.68%-119.34M | ---- |
Dividend (income)- adjustment | 39.16%-5.54M | ---- | 18.41%-9.11M | ---- | -15.72%-11.17M | ---- | 28.88%-9.65M | ---- | -53.58%-13.57M | ---- |
Attributable subsidiary (profit) loss | 72.89%-44.14M | ---- | 30.73%-162.79M | ---- | -10.25%-235M | ---- | 48.34%-213.14M | ---- | -497.64%-412.62M | ---- |
Impairment and provisions: | -77.79%10M | ---- | --45.02M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | -77.79%10M | ---- | --45.02M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | ---- | --23K | ---- | ---- | ---- | -172.92%-70K | ---- |
-Other fair value changes | ---- | ---- | ---- | ---- | --23K | ---- | ---- | ---- | -172.92%-70K | ---- |
Asset sale loss (gain): | 78.29%-2.07M | ---- | -304.93%-9.55M | ---- | 152.98%4.66M | ---- | -30.83%-8.8M | ---- | 94.52%-6.72M | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | 93.77%6.13M | ---- | 808.62%3.16M | ---- | 100.30%348K | ---- |
-Loss (gain) on sale of property, machinery and equipment | 165.94%734K | ---- | 245.26%276K | ---- | -163.55%-190K | ---- | 103.97%299K | ---- | -54.53%-7.53M | ---- |
-Loss (gain) from selling other assets | 71.43%-2.81M | ---- | -670.22%-9.83M | ---- | 89.59%-1.28M | ---- | -2,764.78%-12.26M | ---- | --460K | ---- |
Depreciation and amortization: | 3.42%1.04B | ---- | 16.05%1.01B | ---- | 12.98%870.73M | ---- | 17.36%770.7M | ---- | 27.82%656.68M | ---- |
-Amortization of intangible assets | 4.59%833.85M | ---- | 20.82%797.25M | ---- | 14.08%659.89M | ---- | 20.73%578.45M | ---- | 18.63%479.15M | ---- |
-Other depreciation and amortization | -9.06%-13.21M | ---- | -15.64%-12.11M | ---- | -125.56%-10.47M | ---- | 11.01%40.97M | ---- | -30.18%36.9M | ---- |
Financial expense | 14.44%724.65M | ---- | 35.28%633.23M | ---- | 26.31%468.08M | ---- | -13.66%370.58M | ---- | 34.47%429.22M | ---- |
Special items | 0.64%-481.83M | ---- | -2.25%-484.95M | ---- | -22.53%-474.3M | ---- | -19.47%-387.1M | ---- | -16.14%-324.02M | ---- |
Operating profit before the change of operating capital | -9.30%4.42B | ---- | 10.46%4.88B | ---- | 13.44%4.42B | ---- | 15.37%3.89B | ---- | 11.39%3.37B | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -139.22%-52.02M | ---- | -14.20%132.65M | ---- | 159.65%154.6M | ---- | -163.71%-259.18M | ---- | 45.84%-98.28M | ---- |
Developing property (increase)decrease | -109.91%-21.26M | ---- | 211.93%214.5M | ---- | 22.39%-191.64M | ---- | 5.29%-246.91M | ---- | -34.80%-260.69M | ---- |
Accounts receivable (increase)decrease | 114.65%125.1M | ---- | -82.07%-854.08M | ---- | -278.53%-469.08M | ---- | 411.84%262.75M | ---- | 68.13%-84.26M | ---- |
Accounts payable increase (decrease) | 0.34%1.35B | ---- | 21.14%1.35B | ---- | 2,831.39%1.11B | ---- | -103.49%-40.66M | ---- | 193.97%1.17B | ---- |
prepayments (increase)decrease | 7.29%-214.38M | ---- | 5.04%-231.22M | ---- | -1,216.07%-243.5M | ---- | -120.92%-18.5M | ---- | 112.82%88.43M | ---- |
Special items for working capital changes | -78.54%-1.64B | ---- | -91.60%-916.28M | ---- | -37.67%-478.22M | ---- | -581.61%-347.37M | ---- | 118.12%72.13M | ---- |
Cash from business operations | -12.98%3.98B | ---- | 6.28%4.57B | ---- | 32.56%4.3B | ---- | -23.84%3.24B | ---- | 150.64%4.26B | ---- |
Other taxs | -0.99%-473.57M | ---- | -178.51%-468.94M | ---- | 22.96%-168.37M | ---- | 47.46%-218.55M | ---- | -15.03%-416M | ---- |
Interest paid - operating | -14.44%-724.65M | ---- | -35.28%-633.23M | ---- | -26.31%-468.08M | ---- | 13.66%-370.58M | ---- | -34.47%-429.22M | ---- |
Special items of business | ---- | -10.81%1.15B | ---- | -23.22%1.29B | ---- | 45.50%1.68B | ---- | -24.37%1.16B | ---- | 50.08%1.53B |
Net cash from operations | -19.88%2.78B | -10.81%1.15B | -5.35%3.47B | -23.22%1.29B | 38.01%3.66B | 45.50%1.68B | -22.24%2.65B | -24.37%1.16B | 235.23%3.41B | 50.08%1.53B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 16.85%191.67M | ---- | 32.96%164.03M | ---- | -22.65%123.37M | ---- | 33.65%159.49M | ---- | 23.68%119.34M | ---- |
Dividend received - investment | -60.30%20.31M | ---- | 61.06%51.15M | ---- | 33.70%31.76M | ---- | -5.49%23.75M | ---- | -52.67%25.13M | ---- |
Loan receivable (increase) decrease | 131.94%20.13M | ---- | ---63.03M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | -711.40%-249.89M | ---- | -211.96%-30.8M | ---- | -94.04%27.51M | ---- | 236.16%461.54M | ---- | -261.97%-338.97M | ---- |
Sale of fixed assets | 240.95%4.52M | ---- | -45.97%1.33M | ---- | -76.92%2.45M | ---- | 30.78%10.63M | ---- | -82.28%8.13M | ---- |
Purchase of fixed assets | -28.28%-412.29M | ---- | -25.42%-321.41M | ---- | 54.65%-256.26M | ---- | -118.42%-565.02M | ---- | -15.17%-258.69M | ---- |
Selling intangible assets | -98.29%435K | ---- | 759.57%25.43M | ---- | -92.97%2.96M | ---- | 262.50%42.09M | ---- | --11.61M | ---- |
Purchase of intangible assets | -9.72%-4.73B | ---- | -13.57%-4.31B | ---- | -15.31%-3.79B | ---- | -15.42%-3.29B | ---- | -21.91%-2.85B | ---- |
Sale of subsidiaries | -97.74%8.12M | ---- | 10,114.16%358.42M | ---- | -83.58%3.51M | ---- | -67.62%21.37M | ---- | 671.56%65.99M | ---- |
Acquisition of subsidiaries | ---157.36M | ---- | ---- | ---- | 19.35%-89.92M | ---- | -249.95%-111.49M | ---- | 91.61%-31.86M | ---- |
Recovery of cash from investments | -66.80%135.85M | ---- | 1,951.37%409.19M | ---- | 156.26%19.95M | ---- | -95.73%7.78M | ---- | 2,679.73%182.24M | ---- |
Cash on investment | 80.24%-31.54M | ---- | 33.04%-159.65M | ---- | 61.68%-238.43M | ---- | 37.16%-622.15M | ---- | -12.61%-990.07M | ---- |
Other items in the investment business | 0.83%-236.09M | -33.42%-2.4B | -524.00%-238.06M | 12.83%-1.8B | 68.33%-38.15M | 16.67%-2.06B | -201.82%-120.45M | -4.62%-2.48B | -66.71%118.3M | -45.50%-2.37B |
Net cash from investment operations | -32.13%-5.43B | -33.42%-2.4B | 2.21%-4.11B | 12.83%-1.8B | -5.59%-4.21B | 16.67%-2.06B | -1.10%-3.98B | -4.62%-2.48B | -16.91%-3.94B | -45.50%-2.37B |
Net cash before financing | -311.31%-2.66B | -146.67%-1.25B | -18.93%-645.88M | -33.38%-504.95M | 59.14%-543.08M | 71.27%-378.57M | -152.33%-1.33B | -57.69%-1.32B | 77.60%-526.78M | -37.81%-835.66M |
Cash flow from financing activities | ||||||||||
New borrowing | 2.48%12.16B | ---- | 30.00%11.87B | ---- | 63.92%9.13B | ---- | -8.31%5.57B | ---- | -18.66%6.07B | ---- |
Refund | -9.43%-10.46B | ---- | -71.49%-9.56B | ---- | -13.52%-5.57B | ---- | -39.71%-4.91B | ---- | 1.24%-3.51B | ---- |
Dividends paid - financing | -30.41%-741.67M | ---- | 32.47%-568.71M | ---- | -71.12%-842.12M | ---- | -2.27%-492.11M | ---- | -10.77%-481.21M | ---- |
Absorb investment income | -71.59%41.5M | ---- | 264.22%146.04M | ---- | -62.74%40.1M | ---- | 30.34%107.62M | ---- | -87.00%82.56M | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | -241.58%-117.29M | ---- | ---34.34M | ---- |
Other items of the financing business | -3,063.02%-364.36M | -119.68%-169.75M | 109.10%12.3M | -23.73%862.66M | 79.06%-135.08M | 68.16%1.13B | -740.90%-644.95M | -25.99%672.62M | 133.31%100.63M | -51.67%908.79M |
Net cash from financing operations | -67.57%605.35M | -119.68%-169.75M | -27.77%1.87B | -23.73%862.66M | 598.86%2.58B | 68.16%1.13B | -123.61%-518.06M | -25.99%672.62M | -42.40%2.19B | -51.67%908.79M |
Effect of rate | 50.22%-128.83M | -75.31%-136.35M | -422.36%-258.79M | -525.50%-77.78M | -25.55%80.28M | -19.01%18.28M | 128,264.29%107.83M | 164.04%22.57M | -98.10%84K | -256.65%-35.25M |
Net Cash | -268.02%-2.05B | -495.66%-1.42B | -40.20%1.22B | -52.47%357.71M | 210.50%2.04B | 216.65%752.52M | -210.80%-1.85B | -982.10%-645.1M | 14.39%1.67B | -94.26%73.13M |
Begining period cash | 15.97%6.98B | 15.97%6.98B | 54.38%6.02B | 54.38%6.02B | -30.84%3.9B | -30.84%3.9B | 41.96%5.64B | 41.96%5.64B | 58.21%3.97B | 58.21%3.97B |
Cash at the end | -31.21%4.8B | -13.80%5.43B | 15.97%6.98B | 34.90%6.3B | 54.38%6.02B | -6.90%4.67B | -30.84%3.9B | 25.10%5.02B | 41.96%5.64B | 5.34%4.01B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.